Medical cannabis acts primarily through CB1 and CB2 receptor interactions, with potential analgesic and anti-inflammatory effects that may modulate neurogenic pain pathways associated with cluster headaches. Its cannabinoid components, particularly THC and CBD, can potentially reduce neuronal hyperexcitability and provide symptomatic relief by interrupting pain signaling and inflammatory responses in trigeminal nerve networks.